Article info

Download PDFPDF
Other Hospital Pharmacy topics (including: medical devices)
Cost-effectiveness analysis of febrile neutropenia (FN) prophylaxis with pegfilgrastim in non-Hodgkin's lymphoma (NHL) patients treated with chemotherapy in Spain

Citation

Dominguez-Gil A, Alegre A, Lopez A, et al
Cost-effectiveness analysis of febrile neutropenia (FN) prophylaxis with pegfilgrastim in non-Hodgkin's lymphoma (NHL) patients treated with chemotherapy in Spain

Publication history

  • First published March 12, 2012.
Online issue publication 
March 12, 2012

Related Data

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.